Overview

A Comparative Study Between Foraseq And Formoterol/Budesonide Inhalation Capsules in Patients With Asthma

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This study primary objective is to compare the impact of two products containing budesonide and formoterol as individual capsules with inhalation powder for the pulmonary function of subjects with persistent asthma.
Phase:
Phase 3
Details
Lead Sponsor:
Eurofarma Laboratorios S.A.
Treatments:
Budesonide
Formoterol Fumarate